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• Most cardiac defect s can now be diagnosed during 
fetal life.  
• After birth the defect is confirmed with an 
echocardiogram  (ECHO). 
• If the lesion is associated with the risk of increased 
pulmonary blood flow, monitoring for pulmonary 
hypertension begins. 
• Children are monitored for both an increase in baseline 
pulmonary artery pressures as well as a propensity to 
have a pulmonary vascular bed that is capable of 
constricting suddenly and severely precipitating what is 
commonly called a pulmonary hypertensive crisis.   
• During a crisis, the abrupt elevation in pulmonary artery 
pressure stuns the right ventricle causing it to fail.  The 
failing RV cannot eject blood into the lungs to preload 
the left ventricle and with decreased systemic cardiac 
output, the child’s blood pressure plummets.   
• Avoid and limit strenuous 
exercise. When looking at 
this aspect for children it can 
be complicated since eating 
and playing are what they do.   
(Park, p. 494) 
• Administer oxygen as needed  
(Park, p. 494) 
• Administration of medications 
as prescribed, avoidance of 
abrupt discontinuation of 
medications (Park, p. 496) 
• Ensure that when patient is 
on inhaled Nitric Oxide (iNO) 
that both the Respiratory 
therapist (RRT) and nurse 
collaborate for cares and 
administration of iNO.  
• Sedation and analgesia for 
painful or stimulating 
procedures 
• Pulmonary arterial hypertension 
(PAH) is a medical condition resulting 
in alterations in the small arteries of 
the lung. 
• There are many causes of PAH 
including developmental 
abnormalities of the heart leading to 
increased pulmonary blood flow. 
• After birth, in the normal heart, the 
blood flow is in series and does not 
“mix”.   
• Specific cardiac defects involve 
connections between the pulmonary 
and systemic circulation allowing 
blood to flow into the lower 
resistance system.   
• As the resistance in the pulmonary 
circulation falls following birth and 
clamping of the umbilical cord, 
connections between the two 
systems allow oxygenated blood 
returning from the lungs to recirculate 
back to the lungs rather than being 
delivered to the body.   
• Over time, pulmonary vasculature 
with high blood flow contributes to 
muscularization of the normally thin 
walled pulmonary arteries resulting in 
elevated pressure and increased 
vascular resistance – the hallmarks 
of PAH. 
• Depending upon the cardiac lesion 
and the timing of repair, surgical 
closure of these connections may not 
improve PAH that is long-standing. 
Why Researched 
 
• This topic is extremely relevant to the 
field in which I work, as well as my 
future career as a cardiac nurse. 
• I work as a Registered Nurse (RN) in 
the Heart Center Float Pool at 
Nationwide Children’s Hospital. 
• Children with CHD can in a matter of 
minutes have situations of life and 
death when they have pulmonary 
hypertension and  develop a crisis. 
• It is very important to be up to date 
on the education and information that 
is available for pulmonary 
hypertension in order to educate 
families on the disease. 
 
 Otterbein University, Westerville, Ohio  
Implications for 
Nursing 
• Pulmonary hypertension is a 
rare complication of 
congenital heart disease in 
children.  
• The clinical symptoms, 
evaluation, and  prognosis 
varies greatly from adults. 
• Understanding the 
pathophysiology and the 
available medical therapies 
and interventions  allow us to 
anticipate and prevent crisis 
and stabilize  or reverse the 
early stages of PAH. 
Conclusion 
• Diagnosis of the disease is 
extremely important  since 
changes in pathophysiology 
occur frequently and 
abruptly. 
• Changes to the pulmonary 
bed and the regurgitation of 
the pulmonary valve cause 
right ventricular stress and 
ultimately failure.  
• The RV adapts to the stress 
of PAH with hypertrophy or 
thickening of the ventricular 
wall leading to decreased  
compliance with each 
contraction and inadequate 
pumping. 
• “Right ventricular contraction 
occurs in a peristalsis-like 
manner, beginning with 
contraction of the inlet 
portion and ending with 
contraction of the 
infundibulum” (Bronicki et. El, 
p s15) 
• RV hypertrophy and pressure 
affect the left ventricle's 
ability to fill and eject 
normally.   
• Over time, the RV severely 
compresses the LV leading 





Signs and Symptoms 
• Prolonged exposure to high volume shunts prevents the normal 
remodeling of the pulmonary arteries that occurs after birth.   
• Rather than thin walled vessels in the normal lung, arteries in PAH 
become progressively thicker making the lumen of the vessel 
progressively smaller. 
• “Progressive endothelial dysfunction, medial hypertrophy with 
hyperplasia of smooth muscle cells, increased connective tissue and 
elastic fibers, intimal and adventitial thickening and rarefication of the 
pulmonary arterial tree” (D’Alto et. El p. 3). 
• When looking at any disease process, depending on when the 
disease is found and how quickly the process is evolving, determines 
the possibility of reversibility. At the end stage of the disease process 
following long-term exposure to high volume shunts, the PAH may be 
irreversible. 
Normal lung tissue 
lung tissue with pulmonary hypertension 
• History of heart defects, underlying lung disease, 
syncopal episodes  with activity or stress (Park,  p. 491) 
• Physical assessment- increased right ventricular 
impulse, loud second heart sound, cyanosis, s/s of 
right sided heart failure such as edema or 
hepatomegaly, murmur that is associated with 
pulmonary regurgitation , differential clubbing (Park,  p. 
491) 
• Children with pulmonary hypertension may have 
dyspnea , fatigue, syncopal episodes (Park,  p. 491) 
• Radiology exams- x-ray studies show normal to slightly 
enlarged heart and pulmonary artery. EKG 
demonstrates right ventricular hypertrophy. ECHO may 
show a large RV and RA, thickened RV, pulmonary 
regurgitation, and dilated proximal pulmonary arteries 
(Park,  p. 491) 
• Cardiac Catheterization- directly measures the pressure 
within the RA and RV as well as the pulmonary bed. 
“Right heart catheterization is still the gold standard for 
the diagnosis of PAH and hemodynamic evaluation for 
surgical correction and medical treatment of CHD 
patients” (Fang et. El, p. 1066) 
• Clinical signs of a child experiencing a pulmonary 
hypertensive crisis include abrupt rise in RA and 
pulmonary artery pressures, decreased systemic blood 
pressures, decreased heart rate, ST segment changes, 
decreased cerebral saturations, and decreased pulse 
oximetry. 
